Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1961 1
1963 1
1967 2
1968 4
1969 2
1970 4
1971 4
1972 1
1974 1
1977 1
1978 1
1979 1
1980 1
1981 5
1982 3
1983 2
1984 4
1985 3
1986 3
1987 13
1988 8
1989 10
1990 11
1991 9
1992 8
1993 14
1994 14
1995 13
1996 7
1997 24
1998 17
1999 18
2000 21
2001 28
2002 29
2003 25
2004 18
2005 35
2006 31
2007 24
2008 43
2009 35
2010 29
2011 34
2012 28
2013 43
2014 27
2015 36
2016 39
2017 41
2018 36
2019 51
2020 40
2021 52
2022 54
2023 55
2024 23

Text availability

Article attribute

Article type

Publication date

Search Results

999 results

Results by year

Filters applied: . Clear all
Page 1
A multivalent nucleoside-modified mRNA vaccine against all known influenza virus subtypes.
Arevalo CP, Bolton MJ, Le Sage V, Ye N, Furey C, Muramatsu H, Alameh MG, Pardi N, Drapeau EM, Parkhouse K, Garretson T, Morris JS, Moncla LH, Tam YK, Fan SHY, Lakdawala SS, Weissman D, Hensley SE. Arevalo CP, et al. Among authors: muramatsu h. Science. 2022 Nov 25;378(6622):899-904. doi: 10.1126/science.abm0271. Epub 2022 Nov 24. Science. 2022. PMID: 36423275 Free PMC article.
Updated guidelines for chronic active Epstein-Barr virus disease.
Kawada JI, Ito Y, Ohshima K, Yamada M, Kataoka S, Muramatsu H, Sawada A, Wada T, Imadome KI, Arai A, Iwatsuki K, Ohga S, Kimura H; Committee for Guidelines for the Management of Chronic Active EBV Disease, Related Disorders (the MHLW Research Team in Japan). Kawada JI, et al. Among authors: muramatsu h. Int J Hematol. 2023 Nov;118(5):568-576. doi: 10.1007/s12185-023-03660-5. Epub 2023 Sep 20. Int J Hematol. 2023. PMID: 37728704 Free PMC article. Review.
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice.
Ramos da Silva J, Bitencourt Rodrigues K, Formoso Pelegrin G, Silva Sales N, Muramatsu H, de Oliveira Silva M, Porchia BFMM, Moreno ACR, Aps LRMM, Venceslau-Carvalho AA, Tombácz I, Fotoran WL, Karikó K, Lin PJC, Tam YK, de Oliveira Diniz M, Pardi N, de Souza Ferreira LC. Ramos da Silva J, et al. Among authors: muramatsu h. Sci Transl Med. 2023 Mar 8;15(686):eabn3464. doi: 10.1126/scitranslmed.abn3464. Epub 2023 Mar 8. Sci Transl Med. 2023. PMID: 36867683
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses.
Alameh MG, Tombácz I, Bettini E, Lederer K, Sittplangkoon C, Wilmore JR, Gaudette BT, Soliman OY, Pine M, Hicks P, Manzoni TB, Knox JJ, Johnson JL, Laczkó D, Muramatsu H, Davis B, Meng W, Rosenfeld AM, Strohmeier S, Lin PJC, Mui BL, Tam YK, Karikó K, Jacquet A, Krammer F, Bates P, Cancro MP, Weissman D, Luning Prak ET, Allman D, Locci M, Pardi N. Alameh MG, et al. Among authors: muramatsu h. Immunity. 2021 Dec 14;54(12):2877-2892.e7. doi: 10.1016/j.immuni.2021.11.001. Epub 2021 Nov 4. Immunity. 2021. PMID: 34852217 Free PMC article.
Molecular fate-mapping of serum antibody responses to repeat immunization.
Schiepers A, van 't Wout MFL, Greaney AJ, Zang T, Muramatsu H, Lin PJC, Tam YK, Mesin L, Starr TN, Bieniasz PD, Pardi N, Bloom JD, Victora GD. Schiepers A, et al. Among authors: muramatsu h. Nature. 2023 Mar;615(7952):482-489. doi: 10.1038/s41586-023-05715-3. Epub 2023 Jan 16. Nature. 2023. PMID: 36646114 Free PMC article.
999 results